Field Medical, Inc.

Jul 01, 2025

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce(TM) Pulsed Field Ablation Platform

Apr 23, 2025

FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025

Apr 21, 2025

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

Dec 05, 2024

Field Medical's FieldForce(TM) Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.